VREO Stock Overview
Operates as a cannabis company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Vireo Growth Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.79 |
| 52 Week High | CA$0.99 |
| 52 Week Low | CA$0.28 |
| Beta | 1.26 |
| 1 Month Change | 59.60% |
| 3 Month Change | 23.44% |
| 1 Year Change | 139.39% |
| 3 Year Change | -55.62% |
| 5 Year Change | -33.05% |
| Change since IPO | -84.20% |
Recent News & Updates
Recent updates
Risks Still Elevated At These Prices As Vireo Growth Inc. (CSE:VREO) Shares Dive 26%
Nov 27
Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Oct 12Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Aug 10Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost
Jun 01Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company
Apr 06Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump
Feb 01Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt
Dec 14Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?
Jul 14Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?
Mar 19Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?
Jan 25Shareholder Returns
| VREO | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 102.6% | -0.5% | -2.6% |
| 1Y | 139.4% | -26.7% | 15.2% |
Return vs Industry: VREO exceeded the Canadian Pharmaceuticals industry which returned -26.7% over the past year.
Return vs Market: VREO exceeded the Canadian Market which returned 15.2% over the past year.
Price Volatility
| VREO volatility | |
|---|---|
| VREO Average Weekly Movement | 32.0% |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: VREO's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: VREO's weekly volatility has increased from 22% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 438 | John Mazarakis | www.vireogrowth.com |
Vireo Growth Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
Vireo Growth Inc. Fundamentals Summary
| VREO fundamental statistics | |
|---|---|
| Market cap | CA$181.93m |
| Earnings (TTM) | -CA$24.27m |
| Revenue (TTM) | CA$141.60m |
1.3x
P/S Ratio-7.5x
P/E RatioIs VREO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VREO income statement (TTM) | |
|---|---|
| Revenue | US$98.53m |
| Cost of Revenue | US$48.36m |
| Gross Profit | US$50.17m |
| Other Expenses | US$67.06m |
| Earnings | -US$16.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.073 |
| Gross Margin | 50.92% |
| Net Profit Margin | -17.14% |
| Debt/Equity Ratio | -526.9% |
How did VREO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 11:01 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vireo Growth Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matt Bottomley | Canaccord Genuity |
| Eric Des Lauriers | Craig-Hallum Capital Group LLC |
| Graeme Kreindler | Eight Capital |